John M Limongelli Insider Trading
Get free email notifications about insider trading for John M Limongelli.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John M Limongelli. John M Limongelli is a Sr.VP, General Counsel & Sec in ADOLOR CORP ($ADLR) and a SVP, General Counsel & Secr in ADOLOR CORP ($ADLR) and a SVP, General Counsel & Secr. in ADOLOR CORP ($ADLR) and a SVP, General Counsel,Secretary in ADOLOR CORP ($ADLR) and a SVP,General Counsel &Secretary in ADOLOR CORP ($ADLR) and a Sr. VP,General Counsel & CAO in TREVENA INC ($TRVN) and a Sr. VP,General Counsel & Secy in TREVENA INC ($TRVN) and a SVP & General Counsel in Neos Therapeutics, Inc. ($NEOS).
Address: 700 PENNSYLVANIA DRIVE EXTON 19341 PA
Companies in which John M Limongelli is an Insider
ADOLOR CORP
Trading Symbol: ADLRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John M Limongelli: SVP, General Counsel,Secretary, SVP,General Counsel &Secretary, SVP, General Counsel & Secr., Sr.VP, General Counsel & Sec
Holdings: 0 shares
Latest Transaction: Dec 14 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neos Therapeutics, Inc.
Trading Symbol: NEOSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John M Limongelli: SVP & General Counsel
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 19 2021
$NEOS Market Capitalization: $81.10M
$NEOS Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TREVENA INC
Trading Symbol: TRVNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John M Limongelli: Sr. VP,General Counsel & CAO, Sr. VP,General Counsel & Secy
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 02 2018
$TRVN Market Capitalization: $406.64M
$TRVN Previous Close: $7.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John M Limongelli
Sentiment: All, ADLR, NEOS, TRVN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Option Exercise | D | 1.49 | 115,000 | 171,350 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Option Exercise | D | 3.14 | 150,000 | 471,000 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Sell | D | 0.00 | 83,015 | 0 | 0 | 83 K to 0 (-100.00 %) |
Mar 16 2021 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Payment of Exercise | F | 0.84 | 16,985 | 14,335 | 83,015 | 100 K to 83 K (-16.98 %) |
Mar 04 2020 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Option Exercise | A | 1.49 | 115,000 | 171,350 | 115,000 | |
Mar 04 2020 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Mar 22 2019 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Option Exercise | A | 3.14 | 150,000 | 471,000 | 150,000 |